Nanoscope vs Conventional Arthroscopy for Meniscal Tear
Trial Summary
What is the purpose of this trial?
The study is a pilot study designed to generate preliminary data regarding the cost of partial meniscectomy using NanoScope versus conventional arthroscopy in a traditional operating room (OR) setting
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of this treatment for meniscal tear?
Is the NanoScope technique safe for partial meniscectomy?
How does the treatment using NanoScope differ from other treatments for meniscal tear?
The NanoScope treatment for meniscal tears is unique because it uses a smaller, more flexible endoscope, which allows for better visualization and potentially less invasive surgery compared to conventional arthroscopy. This can lead to reduced recovery time and less trauma to surrounding tissues.13111213
Eligibility Criteria
This clinical trial is for individuals with a meniscal tear, which is an injury to the knee cartilage. Specific eligibility criteria are not provided, so it's important to contact the study organizers for detailed requirements.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Operative
Participants undergo partial meniscectomy using either NanoScope or conventional arthroscopy
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments using IKDC, VAS, and KOOS scores
Treatment Details
Interventions
- Partial Meniscectomy using Conventional Arthroscopy
- Partial Meniscectomy using NanoScope
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arthrex, Inc.
Lead Sponsor